These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

459 related items for PubMed ID: 25736722

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Design, synthesis and evaluation of novel 4-dimethylamine flavonoid derivatives as potential multi-functional anti-Alzheimer agents.
    Luo W, Su YB, Hong C, Tian RG, Su LP, Wang YQ, Li Y, Yue JJ, Wang CJ.
    Bioorg Med Chem; 2013 Dec 01; 21(23):7275-82. PubMed ID: 24148835
    [Abstract] [Full Text] [Related]

  • 4. Design, synthesis and evaluation of flavonoid derivatives as potential multifunctional acetylcholinesterase inhibitors against Alzheimer's disease.
    Li RS, Wang XB, Hu XJ, Kong LY.
    Bioorg Med Chem Lett; 2013 May 01; 23(9):2636-41. PubMed ID: 23511019
    [Abstract] [Full Text] [Related]

  • 5. Galangin, a flavonol derived from Rhizoma Alpiniae Officinarum, inhibits acetylcholinesterase activity in vitro.
    Guo AJ, Xie HQ, Choi RC, Zheng KY, Bi CW, Xu SL, Dong TT, Tsim KW.
    Chem Biol Interact; 2010 Sep 06; 187(1-3):246-8. PubMed ID: 20452337
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Design, synthesis, and evaluation of 7H-thiazolo-[3,2-b]-1,2,4-triazin-7-one derivatives as dual binding site acetylcholinesterase inhibitors.
    Liu S, Shang R, Shi L, Zhou R, He J, Wan DC.
    Chem Biol Drug Des; 2014 Aug 06; 84(2):169-74. PubMed ID: 24890706
    [Abstract] [Full Text] [Related]

  • 8. Combining in silico and in vitro approaches to evaluate the acetylcholinesterase inhibitory profile of some commercially available flavonoids in the management of Alzheimer's disease.
    Kuppusamy A, Arumugam M, George S.
    Int J Biol Macromol; 2017 Feb 06; 95():199-203. PubMed ID: 27871793
    [Abstract] [Full Text] [Related]

  • 9. Design, synthesis and preliminary structure-activity relationship investigation of nitrogen-containing chalcone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors: a further study based on Flavokawain B Mannich base derivatives.
    Liu H, Fan H, Gao X, Huang X, Liu X, Liu L, Zhou C, Tang J, Wang Q, Liu W.
    J Enzyme Inhib Med Chem; 2016 Aug 06; 31(4):580-9. PubMed ID: 26186269
    [Abstract] [Full Text] [Related]

  • 10. Flavonoids as acetylcholinesterase inhibitors.
    Uriarte-Pueyo I, Calvo MI.
    Curr Med Chem; 2011 Aug 06; 18(34):5289-302. PubMed ID: 22087826
    [Abstract] [Full Text] [Related]

  • 11. Syntheses, cholinesterases inhibition, and molecular docking studies of pyrido[2,3-b]pyrazine derivatives.
    Hameed A, Zehra ST, Shah SJ, Khan KM, Alharthy RD, Furtmann N, Bajorath J, Tahir MN, Iqbal J.
    Chem Biol Drug Des; 2015 Nov 06; 86(5):1115-20. PubMed ID: 25951978
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and acetylcholinesterase inhibitory activity of Mannich base derivatives flavokawain B.
    Liu HR, Huang XQ, Lou DH, Liu XJ, Liu WK, Wang QA.
    Bioorg Med Chem Lett; 2014 Oct 01; 24(19):4749-4753. PubMed ID: 25205193
    [Abstract] [Full Text] [Related]

  • 13. Design, synthesis and biological evaluation of dual acetylcholinesterase and phosphodiesterase 5A inhibitors in treatment for Alzheimer's disease.
    Zhou LY, Zhu Y, Jiang YR, Zhao XJ, Guo D.
    Bioorg Med Chem Lett; 2017 Sep 01; 27(17):4180-4184. PubMed ID: 28751142
    [Abstract] [Full Text] [Related]

  • 14. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
    Riaz S, Khan IU, Bajda M, Ashraf M, Qurat-Ul-Ain, Shaukat A, Rehman TU, Mutahir S, Hussain S, Mustafa G, Yar M.
    Bioorg Chem; 2015 Dec 01; 63():64-71. PubMed ID: 26451651
    [Abstract] [Full Text] [Related]

  • 15. Design, synthesis and evaluation of 4-dimethylamine flavonoid derivatives as potential multifunctional anti-Alzheimer agents.
    Luo W, Wang T, Hong C, Yang YC, Chen Y, Cen J, Xie SQ, Wang CJ.
    Eur J Med Chem; 2016 Oct 21; 122():17-26. PubMed ID: 27343850
    [Abstract] [Full Text] [Related]

  • 16. Exploration of multi-target potential of chromen-4-one based compounds in Alzheimer's disease: Design, synthesis and biological evaluations.
    Singh M, Kaur M, Singh N, Silakari O.
    Bioorg Med Chem; 2017 Dec 15; 25(24):6273-6285. PubMed ID: 29089261
    [Abstract] [Full Text] [Related]

  • 17. 4,6-Diphenylpyrimidine Derivatives as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase for the Treatment of Alzheimer's Disease.
    Kumar B, Dwivedi AR, Sarkar B, Gupta SK, Krishnamurthy S, Mantha AK, Parkash J, Kumar V.
    ACS Chem Neurosci; 2019 Jan 16; 10(1):252-265. PubMed ID: 30296051
    [Abstract] [Full Text] [Related]

  • 18. An Efficient Synthesis of bi-Aryl Pyrimidine Heterocycles: Potential New Drug Candidates to Treat Alzheimer's Disease.
    Rehman TU, Khan IU, Ashraf M, Tarazi H, Riaz S, Yar M.
    Arch Pharm (Weinheim); 2017 Apr 16; 350(3-4):. PubMed ID: 28220522
    [Abstract] [Full Text] [Related]

  • 19. Traditional Chinese medicinal herbs as potential AChE inhibitors for anti-Alzheimer's disease: A review.
    Jiang Y, Gao H, Turdu G.
    Bioorg Chem; 2017 Dec 16; 75():50-61. PubMed ID: 28915465
    [Abstract] [Full Text] [Related]

  • 20. Benzofuran-derived benzylpyridinium bromides as potent acetylcholinesterase inhibitors.
    Baharloo F, Moslemin MH, Nadri H, Asadipour A, Mahdavi M, Emami S, Firoozpour L, Mohebat R, Shafiee A, Foroumadi A.
    Eur J Med Chem; 2015 Mar 26; 93():196-201. PubMed ID: 25681712
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.